CompletedNCT02650219

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

Studying Gaucher disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hospital St. Joseph, Marseille, France
Principal Investigator: Christine Serratrice, MD
St joseph France
Intervention: genetic analyses(genetic)
Enrollment: 60 enrolled
Eligibility: 18 years · All sexes
Timeline: 2010 – 2015

Study locations (11)

Internal Medicine Department, Hôpital Minjoz,, Besançon, France
Intensive Care Department, Hôpital Pellegrin,, Bordeaux, France
Internal Medicine Department, Hôpital Beaujon,, Clichy, France
Internal Medicine and Clinical Immunology Department, CHU,, Dijon, France
Internal Medicine Department, Catholic University,, Lille, France
Internal Medicine Department, CHU, Nantes, Nantes, France
Internal Medicine and Rheumatology Department, Hôpital La Croix Saint Simon,, Paris, France
Internal Medicine Department, CHU la Pitié Salpêtrière,, Paris, France
13 Internal Medicine Department, CHU,, Rouen, France
CHRU de Tours, Université François Rabelais, INSERM 1069,, Tours, France
Internal Medicine and Immunology Department, CHU Hôpital Brabois,, Vandœuvre-lès-Nancy, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02650219 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials